Minimizing clinic visits, maximizing use of imaging modalities are key.
Marc D. de Smet, MD, PhD
Advertisement
De Smet is director of MIOS in Lausanne, Switzerland (www.retina-uveitis.eu), and medical director of Preceyes Medical Robotics (www.preceyes.nl) in Eindhoven, The Netherlands.
Articles by Marc D. de Smet, MD, PhD
Advertisement
Latest Updated Articles
Managing neovascular retinal disease in COVID-19 era requires careful approachPublished: April 7th 2021 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
News from Orlando: AAO 2025 highlights research across all areas of eyecare
2
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
3
AAO 2025: Clinical outcomes of early vs delayed pegcetacoplan treatment in GA
4
AAO 2025: Which lens to consider in patients with pseudoexfoliation
5
.png "Optometry Times"){kind=logo}
